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Abstract
Background: Depressive disorders are commonly managed in primary care and family physicians are ideally placed to
serve as central providers to these patients. Around the world, the prevalence of depressive disorders in patients
presenting to primary care is between 10-20%, of which around 50% remain undiagnosed. In Hong Kong, many barriers
exist preventing the optimal treatment and management of patients with depressive disorders. The pathways of care,
the long term outcomes and the factors affecting prognosis of these patients requires closer examination.
Methods/Design: The aim of this study is to examine the prevalence, incidence and natural history of depressive
disorders in primary care and the factors influencing diagnosis, management and outcomes using a cross-sectional
study followed by a longitudinal cohort study.
Doctors working in primary care settings across Hong Kong have been invited to participate in this study. On one
day each month over twelve months, patients in the doctor’s waiting room are invited to complete a
questionnaire containing items on socio-demography, co-morbidity, family history, previous doctor-diagnosed
mental illness, recent mental and other health care utilization, symptoms of depression and health-related quality
of life. Following the consultation, the doctors provide information regarding presenting problem, whether they
think the patient has depression, and if so, whether the diagnosis is new or old, and the duration of the depressive
illness if not a new diagnosis. If the doctor detects a depressive disorder, they are asked to provide information
regarding patient management. Patients who consent are followed up by telephone at 2, 12, 26 and 52 weeks.
Discussion: The study will provide information regarding cross-sectional prevalence, 12 month incidence,
remission rate, outcomes and factors affecting outcomes of patients with depressive disorders in primary care. The
epidemiology, outcomes, pathways of care, predictors for prognosis and service needs for primary care patients
with depressive disorders will be described and recommendations made for policy and service planning.
Background
Depression is a common and serious disorder that results
in decline in functioning and impairment to quality of
life. Unfortunately, despite the availability of effective
treatments, many barriers exist preventing the optimal
detection and management of these patients. Depression
has been identified as a major public health issue in
many parts of the world including Hong Kong [1]. In
Hong Kong, the 12-month general population prevalence
of depressive disorders among adults aged 18-65 years
has been estimated to be approximately 8.4% [2]. This is
similar to the rates in Canada (8.2%) and the US (8.7%)
[3] but higher than those in Australia (6%) [4]. The rate
of doctor-reported depressive disorder in Hong Kong
however has been recorded as only 1.5% [5]. This discre-
pancy implies that there must be a large number of peo-
ple in our community with undiagnosed depression.
Around the world, the prevalence of depressive disor-
ders in patients presenting to primary care has been esti-
mated to be between 10-20%, of which around 50%
remain undetected by doctors [6]. The primary care set-
ting is the point of entry for most people into the health
system and primary care clinicians are ideally placed to
serve as the central health care provider for patients with
depressive disorders. The choice and effectiveness of inter-
vention by primary care doctors can have a profound
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effect on the quality of life of the patients and the demand
for services. However, many challenges exist in providing
optimal care, including difficulties in recognizing patients
with depression, developing an adequate diagnostic initial
assessment, implementing treatment and management
strategies, and integrating care of depression with that of
co-existing chronic illnesses [7].
Depressive disorders are regarded as high prevalence,
chronic conditions with significant impact on quality of life.
Nevertheless, meta-analyses of the long-term outcomes and
factors affecting prognosis remain far from clear [8]. Studies
have shown that one-third to one-half of primary care
patients with depressive disorders have symptoms that per-
sist over six to twelve months, and that severity of symp-
toms, age and presence of co-morbidity were predictors of
this persistence [6,9]. Unfortunately, little else is well under-
stood and much controversy still exists regarding the signif-
icance of detection of these patients on prognosis and
clinical outcomes over time [10]. This lack of clarity may in
part be due to the absence of a ‘gold standard’ by which pri-
mary care doctors diagnose depression, and in part to the
complexity by which multiple factors are considered, before
deciding whether or not to label a patient or initiate therapy
[11]. More recent studies are revealing a more realistic pic-
ture, that diagnosis and management decisions are often
not made on initial consultation, but occurs gradually over
a period of longitudinal care [12].
In order to make recommendations regarding mental
health policy and the planning of mental health services, it
is necessary to have current knowledge of the epidemiol-
ogy and outcomes of depressive disorders managed in the
primary care setting. At this point, there is little local data
available regarding the prevalence and incidence of
depression in Hong Kong’s primary care settings and no
similar studies examining the longitudinal outcomes and
prognosis of these patients.
Methods/Design
Study Design and Objectives
We aim to examine the epidemiology and naturalistic
history (i.e. outcomes of usual care with no added inter-
vention) of depressive disorders in Hong Kong’s primary
care using a cross-sectional study followed by a longitudi-
nal cohort study with the following objectives:
Cross-sectional study
1. Estimate the cross-sectional prevalence of depression
in primary care and its associated demography and co-
morbidities;
2. To examine the criteria by which primary care doc-
tors diagnose depression and the factors that influence
this decision;
3. To describe how primary care doctors manage
depression and the factors influencing their treatment
choices.
Longitudinal Cohort Study
1. To study the natural history of depression and fac-
tors that can predict remission;
2. To estimate the 12 month incidence of depression
in a primary care patient population;
3. To examine the patients’ pathways of care and the
factors influencing treatment.
Participants and Sampling
Cross Sectional Study(Figure 1)
Doctors working in primary care practices across Hong
Kong have been invited to participate in this study. The
doctors were recruited from the mailing list of the Hong
Kong College of Family Physicians (HKCFP) and are com-
prised of clinicians working in private practice, the public
sector and non-profit, non-governmental organizations.
All eligible patients presenting to the study doctor on
one randomly selected day each month during the study
period are invited to participate. The recruitment days are
randomly generated but exclude Sunday and public holi-
days (when most primary care clinics are closed). The
twelve month baseline collection period attempts to
account for seasonal variability and to improve representa-
tion of the primary care case load. Patients are excluded if
they are < 18 years, cannot speak English, Cantonese or
Mandarin, have cognitive or communication difficulties,
have previously been recruited, or are not consulting the
doctor (e.g. vaccination, wound care or prescription refill).
A coded, anonymous questionnaire containing consent
form, questions regarding ethnicity, demographic details,
household income, co-morbid medical conditions, family
history of mental illness, previous doctor-diagnosed men-
tal illness, recent mental and other health care service use,
as well as the PHQ-9, the CES-D 20 and the SF-12v2 is
self administered by each patient whilst in the waiting
room. The questionnaires are available in both English
and Chinese. A trained, bi-lingual research assistant is pre-
sent to explain the study, obtain consent, and distribute
and collect questionnaires. If the subject is unable to self-
administer the questionnaire due to poor literacy, the
research assistant helps to administer the questionnaire.
The doctors are asked to complete a clinical data collec-
tion form for each recruited patient, recording the pre-
senting problem, their opinion on whether the patient has
depression, and whether the diagnosis is new or old. If the
doctor reports a diagnosis of depression, further data is
collected regarding the duration of illness, date of initial
diagnosis and management.
Longitudinal Study (Figure 2)
As part of the baseline cross-sectional survey, patients are
invited to participate in a 12 month cohort study to evalu-
ate the incidence and naturalistic outcomes of care. Those
who consent to enter the cohort study by providing their
names and contact numbers are subsequently followed up
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by telephone (by an interviewer who is blinded to the
initial screening results) with a modified version of the
initial questionnaire and repeated at 2 (for PHQ-9 positive
subjects), 12, 26 and 52 weeks. The participants of the
longitudinal study are stratified according to their initial
PHQ-9 screening result:
Those who are screened negative for depression at
baseline (PHQ-9 score < 9), are followed up to deter-
mine the incidence of depression, and as a control
group for the changes in quality of life.
Those who are screened positive (PHQ-9 score≥9) for
depression are divided into two groups: those where the
doctor has recorded a diagnosis of depression, and those
where the doctor has not recorded a diagnosis of
depression.
The two groups are followed to examine for changes
in symptom severity PHQ-9, quality of life, symptom
remission and health care utilization over the 12 months
and for comparison between the two groups. Symptom
remission is defined as the absence of significant depres-
sive symptoms defined by PHQ-9 score < 5 together
with CES-D 20 score < 16.
Study instruments and screening tools
A. The Patient Health Questionnaire 9 (PHQ-9). The
PHQ-9 is a self-report depression component of the Pri-
mary Care Evaluation of Mental Disorder Procedure
(PRIME-MD) [13] which has been validated in primary
care for diagnosis of depression. It scores each of the 9
DSM-IV criteria from 0 (not at all) to 3 (nearly every day).
It has been calibrated against the Chinese Hamilton
Depression Scale (CHDS) for screening use in Hong Kong
primary care. Using a cut-off point of 9, this tool has a
sensitivity of 80% and specificity of 92% for the diagnosis
of depression [14]. The PHQ-9 can also be used to mea-
sure severity of symptoms (score 1-4 minimal, 5-10 mild,
10-14 moderate, 15-19 moderately severe, 20-27 severe)
and can be used for monitoring symptom progression or
remission over time [15].
B. The Centre for Epidemiologic Studies Depression
Scale (CES-D 20). The CES-D 20 is a widely used self-
report scale which measures the current level of depres-
sive symptomatology in the general population, with an
emphasis on depressed mood during the past week [16].
It has been validated in community and primary care
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Invite?all?eligible?patients?presenting?on?1?randomly?assigned?day?
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Figure 1 Cross-sectional study design.
Chin et al. BMC Family Practice 2011, 12:129
http://www.biomedcentral.com/1471-2296/12/129
Page 3 of 8
populations, and has good test-retest reliability [17]. It
includes 20 items reflecting major dimensions of depres-
sion: depressed mood, feelings of guilt and worthlessness,
feelings of helplessness, psychomotor retardation, loss of
appetite, and sleep disturbance. It has been translated for
use in Hong Kong adults and has been used in epidemio-
logical studies of the Hong Kong general population
[5,18]. Scores range from 0 to 60, with higher scores indi-
cating more severe symptoms of depression. CES-D 20
scores of 16 to 26 are considered indicative of mild
depression and scores of 27 or more indicative of major
depression.
C. The SF-12 Health Survey Version 2.0 (SF-12 v2).
The SF-12 v2 is a 12-item abbreviated version of the SF-
36® Health Survey that assesses health-related quality of
life. The SF-12v2 generates two norm-based summary
scores; a mental component score and a physical compo-
nent score. In a general population the mean score on each
component is 50. The SF-12v2 has been translated and vali-
dated for use in the Hong Kong primary care setting [19].
D. Personal data questions on socio-demography
and co-morbidity is adapted from previously primary
care patient surveys performed in Hong Kong [20].
Sample size calculation
For the estimation of the prevalence of depression by
PHQ-9, we estimated the sample size to ensure an error of
< 2% for an anticipated prevalence of 20% [21]. Without
the consideration of the design effect due to cluster sam-
pling by practice, we need 1540 subjects in total by a 95%
confidence interval. The intraclass correlation (ICC) for
the intra-cluster correlation was taken as 0.02 which is
slightly conservative to the one reported in the DIA-
MOND study [21]. With 50 practices and after accounting
the design effect due to cluster sampling, 80 subjects per
practice are needed.
For the comparison of the two component scores of the
SF-12v2 between subjects diagnosed with depression and
are PHQ-9 positive and subjects with undiagnosed
depression and are PHQ-9 positive, the sample size cal-
culation was based on the analysis by mixed effects
model taking account of the clustering effect by practice.
To adjust multiplicity for the comparisons of the two
component scores, a 2.5% nominal level of significance
was used (by Bonferroni adjustment) in order to control
the overall false positive error rate below 5%. In order to
have 80% power to detect an effect size of 5 with a
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Figure 2 Longitudinal cohort study design.
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slightly conservatively estimated standard deviation of 15
[19] and assume small within cluster correlation of 0.02,
10 subjects per practice for 50 practices are needed [22].
Assuming 50% of the subjects who are initially screened
consent to participate in the longitudinal study and 20%
of them are PHQ-9 positive with a 30% attrition rate, 150
subjects per practice are needed.
For the estimation of the 12-month incidence of depres-
sion on subjects who have no depression by PHQ-9 at
baseline and consent to participate in the longitudinal fol-
low-up study, the sample size was calculated to ensure an
error within 1% for a conservatively estimated 12-month
incidence of depression of 3% (incidence of depression
was 1% to 3% in the literature) [23]. The ICC for the intra-
cluster correlation was again taken as 0.02. With 50 prac-
tices and taking into account of the design effect due to
cluster sampling, 40 subjects without depression per prac-
tice are needed who are followed for 12 months by a 95%
confidence interval [24]. Assuming 50% of the subjects
who are initially screened consent to participate in the
longitudinal study, 80% of them have no depression in
initial screening, and a 30% attrition rate, 150 subjects per
practice are needed.
For the estimation of the resolution rate at 12 months in
subjects who are PHQ-9 positive at baseline and consent
to participate in the longitudinal follow-up study, the sam-
ple size was calculated to ensure at most 5% error in a
95% confidence interval for a conservatively estimated 12-
month resolution rate of depression of 30% [9]. The ICC
for the intra-cluster correlation was again taken as 0.02.
With 50 practices and taking into account the design
effect due to cluster sampling, 8 subjects per practice who
are followed for 12 months are needed [24]. Assuming
50% of the subjects who are initially screened consent to
participate in the longitudinal study, 20% of them have
depression in initial screening, and 30% attrition rate, 115
subjects per practice are needed.
As a result, 150 subjects per practice are needed for a
total of 7500 subjects from 50 practices.
Outcome Measures
The primary outcomes of this study are:
1. the cross-sectional prevalence of depressive disor-
ders in primary care
2. the 12-month incidence rate of depressive disorders
in a primary care population
3. the quality of life of patients with depressive disor-
ders over one year
4. the remission rate over one year
The secondary outcomes of this study are:
1. how patients with depressive disorders are being
managed in primary care
2. factors influencing the clinical diagnosis of
depression
3. factors affecting the outcomes of depressive
disorder
4. the predictors of prognosis of depressive disorders
Possible factors affecting the above outcome measures
will be categorized into:
a) Patient factors: socio-economic status, demogra-
phy, smoking, drinking, co-morbidity, family history
and illness severity
b) Doctor factors: socio-demography, previous edu-
cation and training, system setting (private vs. pub-
lic) and access to service
Statistical analysis
Cross-sectional analysis
The estimation of the prevalence of depression will be
made on the subjects screened at baseline by a 95% confi-
dence interval. The clustering by practice will be taken
into account [25]. In addition, the influence of patient and
doctor factors on depression will also be explored by a
non-linear mixed effects model with logit link that takes
account of the within practice correlation. Specifically,
patient factors will be considered as level 1 covariates and
doctor factors will be considered as level 2 covariates.
Similar analyses will be pursued on the diagnosis of
depression by doctors.
Longitudinal analysis
The 12-month incidence of depression among the PHQ-9
negative group at baseline will be similarly estimated as in
the prevalence of depression. Patient and doctor factors
associated with the incidence of depression will also be
examined by non-linear mixed effects model. The physical
and mental component scores of the SF-12v2 as well as
other health outcomes of PHQ-9 positive subjects will be
compared by a linear mixed effects model. Confounding
factors, including socio-demographics will be adjusted.
Effects of patient and doctor factors will also be examined
in a linear mixed effect model analysis with patient factors
taken as level 1 covariates and doctor factors taken as level
2 covariates. The same analyses will be performed for the
12-month resolution rate of depression in subjects who
are PHQ-9 positive at baseline.
A 5% level of significance will be used and all estimates
will be accompanied by a 95% confidence interval where
appropriate. The Statistical Analysis System (SAS) or
other competent statistical software will be used to carry
out the analyses.
Ethics Approvals
This study has received ethics approval by the Institutional
Review Board of the University of Hong Kong/Hospital
Authority Hong Kong West Cluster, the Research Com-
mittee of Hong Kong Sanatorium and Hospital, the
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Research Ethics Committee for Hong Kong Hospital
Authority Kowloon East and Kowloon Central, and the
Joint Chinese University of Hong Kong and Hong Kong
Hospital Authority New Territories East Clinical Ethics
Review Committee.
Discussion
The establishment of a primary care practice-based
study involving a large number of individual practices
requires a great deal of preliminary coordination, and
there were a number of initial challenges which had to
be overcome.
Recruitment of Doctors and Practices
As there is no comprehensive registry of primary care
providers in Hong Kong, we used the 1500-member
mailing list of the Hong Kong College of Family Physi-
cians (HKCFP) as our sampling population from which
we invited doctors to participate. Following the initial
mailing and follow-up bulk-email, we received only 70
responses. Of those who responded, three were retired or
no longer practicing in Hong Kong, 12 were not eligible
(employer did not allow their participation in the study
or doctor did not work in a primary care setting), and 15
declined after receiving more information regarding the
study. For the 15 who declined, their cited reasons were
concerns regarding the impact of the study on their tight
working schedule, that they saw too few patients, and
concerns regarding patient confidentiality. Of the 40 doc-
tors that were eligible, the demographic spread was
unevenly distributed. To overcome this, we employed a
snow-balling technique (asking doctors to refer local col-
leagues to the study) in under sampled demographic
areas which proved to be very useful. By the end of the
doctor recruitment period we had 60 doctors from 45
different practice locations demographically distributed
across Hong Kong. In terms of type of practice, 25 of the
60 doctors worked in private solo clinics, 8 in private
group clinics, 11 in private hospital clinics, 11 in public-
sector clinics, 2 in university health services, and 3 in
non-profit non-governmental organisations.
Patient recruitment
Although a standardized patient recruitment procedure
was initially developed, recruitment logistics had to be
tailor-made for each practice site due to significant varia-
bility in patient flow and logistics. Patient recruitment
has been quite straight forward at solo private practices,
but we have encountered difficulties at large multi-disci-
plinary clinics due to high patient volumes coupled with
shorter consultation times. At these large clinics, identi-
fying which patients to approach has been a major obsta-
cle to subject recruitment. This barrier can be overcome
by enlisting the help of nursing and clerical staff to
identify appropriate patients, and by sending two field
workers per doctor to minimise missed patients.
Study Instruments
At baseline and all follow-up interviews, both the PHQ-9
and CES-D 20 are administered. We found that some
patients (particularly the elderly) got annoyed as it seems
that the same question is asked twice, and some items are
difficult for them to answer. This can be overcome by
reinforcing the training of the interviewers on how to best
explain the items requiring clarification, and how to
encourage the subjects to choose the best available answer
even though they may not be absolutely sure.
Response rate
Patient recruitment commenced over the various sites
between October 2010 and April 2011. Response rates to
the baseline questionnaire have ranged from 73.9% to
85.6%; however the response rate for the cohort study was
initially as low as 25%. In an attempt to enhance the
cohort response rate, we send quarterly newsletters to all
our study doctors providing them with an update of the
study progress, and encouraging them to promote the
cohort study. We reduced the length of the follow-up
questionnaires by removing redundant questionnaire
regarding demography and health care preferences. We
also modified the protocol by removing the 2-week tele-
phone follow-up for those who were PHQ-9 negative at
baseline. A very useful strategy has been to reinforce the
training of our field workers on how to explain the study’s
purpose to the subjects, emphasising why the knowledge
gained could benefit others. Following the implementation
of these strategies, the cohort response rate rose to 48%.
Staffing issues
Observational practice-based studies are logistically com-
plex and can be manpower intensive. Maintaining a stable
and well-trained team of research assistants is needed to
enhance the efficacy and quality of practice-based studies
such as ours. In total, it has been necessary to employ
three full-time and three part-time research assistants to
maintain patient recruitment. In addition, a casual staff
pool has been used to conduct telephone follow-up inter-
views and input data. An experienced project coordinator
to liaise between various parties, and who is available for
urgent troubleshooting is essential for the smooth running
of the study.
Strengths and Weaknesses
One of the major strengths of this study has been our suc-
cess in recruiting a large number of primary health care
providers to collaborate in this study. There are many ser-
vice delivery options for patients seeking primary care in
Hong Kong and our wide sampling of practice types
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captures this diversity. To date, there has been no similar
wide scale epidemiological study on the prevalence and
incidence of depression in the Hong Kong adult primary
care population. An unexpected side benefit has been the
generation of interest in participating in research, and
identification of a number of individual family physicians
seeking further research skills development and academic
collaboration.
As there is no comprehensive registry of primary care
providers for Hong Kong, the mailing list of the Hong
Kong College of Family Physicians was chosen as the pri-
mary sample frame for the doctors. A limitation of this
study is that doctors who provide primary care, but are
not members of the College, have not been deliberately
sampled.
Recruitment for the cross-sectional study will continue
until January 2012, and the cohort study until Jan 2013.
The findings from this study should help provide informa-
tion on the predictors of prognosis in primary care depres-
sion as well as identify which services are in greatest need
and for whom they are most needed. If confirmed, these
predictors can be incorporated into mental health policies
to better help those at high risk of poor outcome, and
enable decision-makers to more effectively allocate mental
health resources for the community.
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